Eckert & Ziegler
Price
Price
Historical dividends and forecast
Eckert & Ziegler has so far distributed $0.0537 in 2024. The next dividend will be paid on 01.07.2025
CHART BY
Frequently asked questions
What is Eckert & Ziegler's market capitalization?
What is Eckert & Ziegler's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Eckert & Ziegler?
What are the analyst ratings and target price for Eckert & Ziegler's stock?
What is Eckert & Ziegler's revenue over the trailing twelve months?
What is the EBITDA for Eckert & Ziegler?
What is the free cash flow of Eckert & Ziegler?
What is the 5-year beta of Eckert & Ziegler's stock?
How many employees does Eckert & Ziegler have, and what sector and industry does it belong to?
What is the free float of Eckert & Ziegler's shares?
Financials
Market Cap
$820.18M5Y beta
1.11EPS (TTM)
$1.477Free Float
14.20MP/E ratio (TTM)
26.23Revenue (TTM)
$290.91MEBITDA (TTM)
$78.11MFree Cashflow (TTM)
$34.44MPricing
Analyst Ratings
The price target is $65.37 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
1,143
Biotechnology & Drugs
Information Technology
Identifier
ISIN
Primary Ticker